The red algal genus Portieria is a prolific producer of halogenated monoterpenoids. In this study, we isolated and characterised monoterpenoids from the Okinawan red algae Portieria hornemannii . A new polyhalogenated cyclic monoterpenoid, 2( R )‐chloro‐1,6( S )‐dibromo‐3(8)( Z )‐ochtoden‐4( R )‐ol ( 1 ), along with three known monoterpenoids, (2 R ,3(8) E ,4 S ,6 R )‐6‐bromo‐2‐chloro‐1,4‐oxido‐3(8)‐ochtodene ( 2 ), 1‐bromo‐2‐chloroochtoda‐3(8),5‐dien‐4‐one ( 3 ), and 2‐chloro‐1‐hydroxyochtoda‐3(8),5‐dien‐4‐one ( 4 ) were isolated from the methanol extract of three populations of P. hornemannii . These compounds were characterised using a combination of spectroscopic methods and chemical synthesis, and the absolute stereochemistry of compounds 1 and 2 was determined. In addition, all isolated compounds were screened for their anti‐biofouling activity against the mussel Mytilus galloprovincialis , and 1 exhibited strong activity. Therefore, halogenated monoterpenoids have the potential to be used as natural anti‐biofouling drugs.
No takes yet. Share an insight, caveat, or question.
Ishigami et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: